[Treatment of atherosclerosis].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy*; D004035:Diet Therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010208:Papaverine / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D008996:Monoamine Oxidase Inhibitors; D014665:Vasodilator Agents; D013806:Theophylline; D010208:Papaverine
Tratamiento de la aterosclerosis.